« Back
Home /
Vapreotide

Vapreotide

Item no.	HY-P0061-10mg
Manufacturer	MedChem Express
CASRN	103222-11-3
Amount	10 mg
Quantity options	100 mg 10mM/1mL 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Neuroscience Neuroinflammation Metabolism Diabetes Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.06
Formula	C57H70N12O9S2
Citations	[1]Spitsin S et al. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. Neuroimmunomodulation. 2013;20(5):247-55.
Smiles	O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)CC2=CNC3=CC=CC=C23)=O)NC([C@H](N)CC4=CC=CC=C4)=O)=O)CC5=CC=C(C=C5)O)N[C@@H]1CC6=CNC7=CC=CC=C67
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	RC160; BMY 41606
Available
Product Description	Vapreotide is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.
StorageTemperature	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Shipping	Blue Ice
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	1131.37
Clinical Information	Launched
Manufacturers Research Area	Cancer
Solubility	H2O : 100 mg/mL (ultrasonic)
Target	Neurokinin Receptor
Manufacturers Target	Neurokinin Receptor
Isoform	NK1
Manufacturers Pathway	GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P0061-10mg-safety-datasheet.pdf